Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities (2011 - 2020)
Iovance Biotherapeutics (IOVA) posted quarterly Other Non-Current Liabilities of $11.7 million for Q4 2020, up 398.04% year-over-year from $2.4 million in Q1 2020, and up 398.04% quarter-over-quarter from $2.4 million in Q3 2020.
Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities (2011 - 2020) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other Non-Current Liabilities for 5 consecutive years, with $11.7 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Other Non-Current Liabilities rose 398.04% year-over-year to $11.7 million; the TTM figure through Dec 2020 stood at $11.7 million (up 398.04% YoY), while the FY2020 annual figure was $11.7 million, up 398.04% from the prior year.
- Other Non-Current Liabilities climbed to $11.7 million in Q4 2020 per IOVA's latest filing, from $2.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $11.7 million in Q4 2020 and bottomed at $53000.0 in Q1 2019.
- Historically, Other Non-Current Liabilities has averaged $2.4 million across 3 years, with a median of $2.4 million in 2019.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 4337.74% in 2020 and fell as far as 398.04% in 2020.
- Iovance Biotherapeutics' Other Non-Current Liabilities stood at $230000.0 in 2018, then surged by 922.61% to $2.4 million in 2019, then jumped by 398.04% to $11.7 million in 2020.
- Business Quant data shows IOVA's Other Non-Current Liabilities at $11.7 million in Q4 2020, $2.4 million in Q3 2020, and $2.4 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 11.71 Mn |
| Sep 30, 2020 | 2.35 Mn |
| Jun 30, 2020 | 2.35 Mn |
| Mar 31, 2020 | 2.35 Mn |
| Dec 31, 2019 | 2.35 Mn |
| Sep 30, 2019 | 53,000.00 |
| Jun 30, 2019 | 53,000.00 |
| Mar 31, 2019 | 53,000.00 |
| Dec 31, 2018 | 230,000.00 |
| Sep 30, 2012 | 7.66 Mn |
| Jun 30, 2012 | 8.74 Mn |
| Dec 31, 2011 | 7.94 Mn |
| Jun 30, 2011 | 7.94 Mn |